(IN BRIEF) Sanofi has received a positive recommendation from the European Medicines Agency’s CHMP for the conditional approval of Rezurock to treat late-line chronic graft-versus-host disease in adults and adolescents aged 12 and older. The opinion, based on clinical trial … Read the full press release
Posted in European Union, France, Healthcare, Marketing, Pharma & Biotech
Tagged belumosudil, CHMP, CHMP Recommends Conditional EU Authorisation for Sanofi’s Rezurock to Treat Late-Line Chronic GVHD, chronic graft-versus-host disease, clinical trials, conditional marketing authorisation, EU regulatory approval, European Medicines Agency, GVHD, haematology, rare diseases, Rezurock™, ROCK2 inhibitor, ROCKstar study, Sanofi, stem cell transplant
(IN BRIEF) The University of Liverpool and the University of Medicine and Pharmacy at Ho Chi Minh City have signed a Memorandum of Understanding establishing a long-term partnership focused on data science and artificial intelligence innovation for healthcare. Signed during … Read the full press release
Posted in Artificial Intelligence (AI), Education, Healthcare, Internet & Online, Pharma & Biotech, Science, Technology, United Kingdom
Tagged academic partnership, artificial intelligence, biomedical informatics, Civic Health Innovation Labs, data science, Department of Public Health Policy and Systems, digital health, Faculty of Health and Life Sciences, health systems resilience, Healthcare Innovation, Institute of Population Health, Liverpool City Council, Liverpool City Region, Memorandum of Understanding, public health research, UK Vietnam collaboration, UMP HCMC, University of Liverpool Strengthens UK–Vietnam Health Innovation Ties Through AI-Focused Collaboration with UMP HCMC University of Liverpool, University of Medicine and Pharmacy at Ho Chi Minh City
(IN BRIEF) DNV has led a growth financing round of up to €37 million for Recare, enabling the Berlin-based health tech company to scale its AI-driven platform for hospital discharge and aftercare coordination. With participation from CIBC Innovation Banking, the … Read the full press release
Posted in Artificial Intelligence (AI), Berlin, Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Norway, Technology
Tagged aftercare coordination, AI agents, Charlotte Goggin, CIBC Innovation Banking, Daniel Holth Larsen, digital health investment, discharge management, DNV, DNV Backs Recare with Major Growth Investment to Advance AI Automation in Hospital Operations, health technology, healthcare AI, healthcare workforce shortages, hospital automation, Maximilian Greschke, Recare, SaaS healthcare platforms
(IN BRIEF) AstraZeneca has announced a $15 billion investment in China through 2030 to expand research, development and manufacturing capabilities, supporting its long-term growth strategy and global pipeline in advanced treatment modalities such as cell therapy and radioconjugates. The investment … Read the full press release
Posted in Business, Healthcare, Investment, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged advanced medicines, AstraZeneca, AstraZeneca Accelerates 2030 Strategy with $15 Billion China Investment in Breakthrough Therapies and Manufacturing, biopharmaceutical expansion, cell therapy, China investment, China UK healthcare collaboration, global R&D centres, healthcare ecosystem, Healthy China 2030, Keir Starmer, life sciences strategy, oncology innovation, Pascal Soriot, pharmaceutical manufacturing, radioconjugates, research and development
(IN BRIEF) Bertelsmann Investments has launched Bertelsmann Healthcare Investments (BHI), a new independent, transatlantic healthcare-focused investment fund with operations in Europe and the United States. Building on years of successful healthcare investments and a first major exit with AI company … Read the full press release
Posted in Germany, Healthcare, Investment, Management, News, Technology
Tagged AI in healthcare, Bertelsmann Healthcare Investments, Bertelsmann Investments, Bertelsmann Investments Launches Bertelsmann Healthcare Investments to Scale Transatlantic Healthcare Innovation, BHI fund, Carsten Coesfeld, digital health, global VC ecosystem, healthcare entrepreneurship, Healthcare Innovation, healthcare venture capital, Phare Health, R1 acquisition, Thorsten Wirkes, Tim Schneider, Transatlantic Investment
(IN BRIEF) CERSI-PGx has launched a free eLearning portal to support the adoption of pharmacogenomics in routine clinical practice. Led by the University of Liverpool in partnership with the British Pharmacological Society and Queen Mary University of London, the platform … Read the full press release
Posted in Education, Healthcare, Internet & Online, Pharma & Biotech, Science, Technology, United Kingdom
Tagged British Pharmacological Society, CERSI PGx, eLearning portal, Faculty of Health and Life Sciences, genomic guided prescribing, genomic medicine, healthcare education Department of Pharmacology and Therapeutics, Innovate UK, Institute of Systems Molecular and Integrative Biology, Maria Tsakiroglou, New CERSI-PGx eLearning Platform Aims to Equip Healthcare Professionals for Genomic-Guided Prescribing, NHS genomics, personalised medicine, pharmacogenomics, Queen Mary University of London, regulatory science, Sir Munir Pirmohamed, Therapeutics Innovation, University of Liverpool
(IN BRIEF) Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental glomerulosclerosis. Published in The Lancet, the study showed a 40% reduction in proteinuria … Read the full press release
Posted in Germany, Healthcare, Management, News, Pharma & Biotech, Science
Tagged apecotrep BI 764198, Boehringer Ingelheim, Boehringer Ingelheim Advances Targeted Kidney Disease Pipeline with Promising Phase II Data for Apecotrep in FSGS, FSGS, Howard Trachtman, kidney disease research, non immunosuppressive therapy, Paola Casarosa, Phase II clinical trial, Phase III clinical development, podocyte protection, primary focal segmental glomerulosclerosis, proteinuria reduction, rare kidney diseases, renal disease innovation, TRPC6 inhibitor
(IN BRIEF) The Institute of Cancer Research, London, has led the development of OPTIMISE-ROR, the first structured guidance outlining how patient-reported outcomes should be used in early-stage cancer dose-finding trials. Published in the Journal of Clinical Oncology, the recommendations provide … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer Research UK, Christina Yap, clinical trials methodology, dose-finding studies, early-stage cancer trials, Emily Alger, Experimental Cancer Medicine Centre, ICR, Institute of Cancer Research Develops First Foundational Framework for Patient-Reported Outcomes in Early Oncology Trials, Institute of Cancer Research London, International Study Led by ICR Strengthens Role of Patient Experience in Early-Phase Cancer Drug Development, Journal of Clinical Oncology, oncology research, OPTIMISE-ROR, patient-reported outcomes, PROs
(IN BRIEF) The Institute of Cancer Research has welcomed NICE’s recommendation of talazoparib in combination with enzalutamide for adults with metastatic prostate cancer, providing a new treatment option for around 2,400 patients in England who are unsuitable for chemotherapy. Backed … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged BRCA mutations, DNA repair gene mutations, enzalutamide, Institute of Cancer Research London, metastatic prostate cancer, NICE recommendation, NICE Recommendation of Talazoparib Marks New Treatment Option for Advanced Prostate Cancer, PARP inhibitors, prostate cancer treatment, Royal Marsden NHS Foundation Trust, TALAPRO trials, talazoparib, Talzenna, targeted cancer therapy
(IN BRIEF) EQT has announced a USD 371 million tender offer to acquire MAMEZO, a Tokyo-based IT services company specialising in IT modernisation and AI-driven digital transformation. The transaction marks EQT’s first investment in Japan’s IT services sector and aligns … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, Investment, Management, Sweden, Technology
Tagged artificial intelligence adoption, BPEA EQT Mid-Market Growth Partnership, digital transformation, EQT, EQT Launches Tender Offer to Acquire Japanese IT Services Firm MAMEZO, IT modernisation, Japan IT services, MAMEZO, mid-market buyout strategy, Private equity investment, technology-enabled services, tender offer, Tokyo headquarters
(IN BRIEF) GSK has secured approval in China for Trelegy Ellipta as a maintenance treatment for adults with asthma, adding to its existing indication in COPD and making it the only single inhaler triple therapy approved for both conditions in … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged asthma treatment China, CAPTAIN study, chronic respiratory disease, COPD treatment, FF UMEC VI, GSK, GSK Expands Respiratory Portfolio in China with Asthma Approval for Trelegy Ellipta, inhaled therapy, National Medical Products Administration, respiratory medicine, single inhaler triple therapy, Trelegy Ellipta, uncontrolled asthma
(IN BRIEF) City College Norwich has signed the University of East Anglia’s Civic Charter, reaffirming a long-standing partnership focused on inclusive education, skills development, and civic engagement across Norfolk. The agreement reflects shared commitments to widening participation, aligning education with … Read the full press release
Posted in Education, Healthcare, Society, United Kingdom
Tagged City College Norwich, City College Norwich Reaffirms Civic Commitment Through UEA Civic Charter Partnership, Civic Engagement, Community Impact, higher education partnerships, inclusive education, Norfolk education, postgraduate teaching, regional collaboration, skills development, UEA Civic Charter, University of East Anglia, widening participation
(IN BRIEF) Beiersdorf has expanded its Health Care portfolio with the launch of Second Skin Protection Spray Plaster and Liquid Plaster Concentrate under the Hansaplast, Elastoplast, and CURITAS brands, targeting consumers who avoid traditional plasters. The two invisible formats address … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, Investment, Marketing, News, Technology
Tagged Beiersdorf, Beiersdorf Strengthens Health Care Growth Strategy with Spray and Liquid Second Skin Innovations, consumer health, CURITAS, Elastoplast, Global Expansion, Hansaplast, Health Care Business, invisible plaster, liquid plaster, Second Skin Protection, skin protection, spray plaster, sustainability packaging, Win with Care strategy, wound care innovation
(IN BRIEF) Prudential plc has agreed to acquire an additional 19% stake in Sri Han Suria Sdn. Bhd., increasing its total ownership of Prudential Assurance Malaysia Berhad to 70% and reinforcing its long-term commitment to the Malaysian insurance market. The … Read the full press release
Posted in Business, Healthcare, Insurance, Investment, Management, United Kingdom
Tagged Bank Negara Malaysia, capital allocation, Detik Ria Sdn Bhd, financial services expansion, insurance investment, Malaysia life insurance, ownership increase, Prudential Assurance Malaysia Berhad, Prudential Corporation Holdings Limited, Prudential Expands Stake in Prudential Assurance Malaysia to 70% Following Regulatory Approval, Prudential plc, Southeast Asia insurance market, Sri Han Suria Sdn Bhd
(IN BRIEF) Rīga Stradiņš University (RSU) will host the BFCS 2026 international conference on 19–20 March 2026 in Riga, Latvia, in collaboration with the Baltic Flow Cytometry Society. The two-day event will bring together flow cytometry specialists, clinicians, and researchers … Read the full press release
Posted in Education, Healthcare, Latvia, Pharma & Biotech, Science, Technology
Tagged abstract submission, Baltic Flow Cytometry Society, BFCS, BFCS 2026, biomedical research, clinical research, early-career researchers, flow cytometry, immunology, Institute of Microbiology and Virology, interdisciplinary collaboration, international scientific conference, microbiology, oncology, PhD students, postdoctoral fellows, Riga Latvia, Rīga Stradiņš University, RSU, scientific networking, virology, Young Researcher Awards
(IN BRIEF) EMA has appointed Carmen Purdel as the new Chair of the Committee for Herbal Medicinal Products, with a three-year mandate starting on 2 March 2026. A long-standing member of the committee since 2011, Purdel brings regulatory and academic … Read the full press release
Posted in European Union, Healthcare, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Carmen Purdel, Carmen Purdel Named Chair of EMA’s Herbal Medicinal Products Committee, Carmen Purdel to Lead EMA Committee for Herbal Medicinal Products From March 2026, Committee for Herbal Medicinal Products, EMA, Emiel van Galen, EU medicines regulation, European Medicines Agency, herbal medicinal products, HMPC, Medicines Evaluation Board, National Agency for Medicines and Medical Devices Romania, Real-World Data, regulatory harmonisation, traditional herbal medicines, University of Medicine and Pharmacy Bucharest
(IN BRIEF) Nagarro and Enterprise Training Center have announced the continuation and expansion of the TestingPro initiative in Austria, developing it into the country’s first dual IT training program for people on the autism spectrum. Starting in spring 2026, the … Read the full press release
Posted in Artificial Intelligence (AI), Germany, Healthcare, Management, News, Society, Technology
Tagged Austria IT training, autism spectrum, digital skills, dual training program, Enterprise Training Center, ETC, inclusive employment, ISTQB certification, IT workforce development, mentoring and coaching, Nagarro, Nagarro Supports Inclusive IT Careers With Expanded TestingPro Training Model in Austria, neurodiversity in tech, practical internships, quality assurance, software testing, talent development, TestingPro, TestingPro Enters New Phase as Nagarro and ETC Strengthen Dual Training Approach
(IN BRIEF) DNV has certified Clearlab’s contact lenses and multi-purpose lens care solutions under the Medical Device Single Audit Program, ISO 13485, and the EU Medical Device Regulation through a parallel audit process. This integrated approach enabled Clearlab to achieve … Read the full press release
Posted in Business, Healthcare, Industrial, Management, News, Norway, Pharma & Biotech, Technology
Tagged Asia Pacific, Clearlab, contact lenses, DNV, DNV Certifies Clearlab Contact Lens Products Under Global Medical Device Standards, DNV Completes Parallel Audit for Clearlab Contact Lenses and Lens Care Solutions, EU MDR 2017/745, Europe, Global market access, ISO 13485, lens care solutions, MDSAP, medical device certification, Medical Device Regulation, medical devices, parallel audit, patient safety, quality management systems, regulatory compliance
(IN BRIEF) Empa has developed polymer-based, MRI-compatible electrode cables in collaboration with Swiss company TI Solutions AG, addressing long-standing safety and performance challenges associated with using conductive materials inside MRI scanners. By replacing traditional copper wiring with polymer fibers coated … Read the full press release
Posted in Healthcare, Pharma & Biotech, Science, Switzerland, Technology
Tagged Advanced Fibers laboratory, diagnostic technology, Dirk Hegemann, ECG, EEG, Empa, Empa Introduces Scalable Polymer Fiber Cables Designed for Safe Use in MRI Environments, Innosuisse, magnetic resonance imaging, magnetron sputtering, medical imaging, medical research, MRI, MRI-compatible cables, neurostimulation, Niels Kuster, polymer cables, silver titanium coating, Sven Kühn, temporal interference stimulation, TI Solutions AG
(IN BRIEF) EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, led through the LSP Dementia … Read the full press release
Posted in Healthcare, Investment, Pharma & Biotech, Sweden
Tagged agitation, Alzheimer’s disease, Andera Partners, dementia care, Deraphan, EQT Life Sciences, Exciva, Exciva Raises €51 Million Series B to Support Phase 2 Trial for Alzheimer’s Agitation Treatment, Fountain Healthcare Partners, Gimv, Juliette Lee, LBBW, LifeArc, LSP Dementia Fund, neuropsychiatric symptoms, neuroscience therapeutics, Phase 2 clinical trial, Philip Scheltens, Series B financing
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?